Glaukos Corp.

GKOS ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $507.4M $383.5M $314.7M $282.9M $294.0M $225.0M $237.0M
Cost of Revenue $111.8M $94.0M $75.6M $69.0M $66.6M $91.7M $38.6M
Gross Profit $282.8M $289.5M $239.1M $213.9M $227.4M $133.2M $198.4M
Gross Margin 55.7% 75.5% 76.0% 75.6% 77.3% 59.2% 83.7%
Operating Expenses
Research & Development
SG&A Expense $331.7M $261.2M $224.1M $192.9M $179.3M $171.4M $176.6M
Operating Income $-199.6M $-122.4M $-128.7M $-82.3M $-32.9M $-123.6M $-50.3M
Operating Margin -39.3% -31.9% -40.9% -29.1% -11.2% -54.9% -21.2%
Interest Expense $13.6M $13.7M $13.4M $14.1M $2.6M
Pretax Income $-193.0M $-145.6M $-133.7M $-98.4M $-49.3M $-132.3M $-50.0M
Income Tax Expense $-5.4M $771.0K $934.0K $766.0K $326.0K $-12.0M $-65.5M
Net Income $-187.7M $-146.4M $-134.7M $-99.2M $-49.6M $-120.3M $15.4M
Net Margin -37.0% -38.2% -42.8% -35.1% -16.9% -53.5% 6.5%
EPS (Basic) $-3.28 $-2.77 $-2.78 $-2.09 $-1.07 $-2.70 $0.41
EPS (Diluted) $-3.28 $-2.77 $-2.78 $-2.09 $-1.07 $-2.70 $0.37
Shares Outstanding (Basic) 58.1M 57.2M 52.8M 48.4M 47.4M 46.4M 44.5M 37.4M
Shares Outstanding (Diluted) 58.1M 57.2M 52.8M 48.4M 47.4M 46.4M 44.5M 41.1M
Dividends Per Share
← Newer Page 1 of 2 Older →